ANDRA TALASKA: Open Payments
NPI 1336537877 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,595 in 142 payments from 27 companies in 2025. Trend: 2023 $1,732 · 2024 $1,704 · 2025 $2,595
Food & beverage: $2,595
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $334 |
| Abbott Laboratories | 6 | $300 |
| Novartis Pharmaceuticals Corporation | 21 | $289 |
| E.R. Squibb & Sons, L.L.C. | 25 | $277 |
| Novo Nordisk Inc | 6 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $173 |
| Amgen Inc. | 8 | $140 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 14 | $104 |
| Medtronic, Inc. | 2 | $99 |
| BridgeBio Pharma, Inc. | 5 | $94 |
Products named: LEQVIO, VYNDAQEL, CAMZYOS, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Kerendia, Wegovy, ELIQUIS, REPATHA.
Industry payments across MI — which companies pay providers there.
